Hepatocyte growth factor increases expression of vascular endothelial growth factor and plasminogen activator inhibitor-1 in human keratinocytes and the vascular endothelial growth factor receptor flk-1 in human endothelial cells

Laboratory Investigation

Volumn 79, Issue 4, 1999, Pages 427-438

  Wojta, Johann ^b   Kaun, Christoph ^c   Breuss, Johannes M ^c   Koshelnick, Yuri ^c   Beckmann, Renate ^c   Hattey, Elfriede ^c   Mildner, Michael ^c   Weninger, Wolfgang ^c   Nakamura, Toshikazu ^c   Tschachler, Erwin ^a   Binder, Bernd R ^c  

^a Ctr Reserche d'Invest E   (France)

^b UNIVERSITY OF VIENNA   (Austria)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1; SCATTER FACTOR; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ARTICLE; CELL MIGRATION; CELL PROLIFERATION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; KERATINOCYTE; LIVER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN INJURY; TISSUE REPAIR; WOUND HEALING;

ANIMALS; CELL DIVISION; CELL LINE, TRANSFORMED; CELLS, CULTURED; COCULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; GROWTH SUBSTANCES; HEPATOCYTE GROWTH FACTOR; HUMANS; KERATINOCYTES; LYMPHOKINES; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, MITOGEN; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; RECOMBINANT PROTEINS; TISSUE PLASMINOGEN ACTIVATOR; UMBILICAL VEINS; URINARY PLASMINOGEN ACTIVATOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0032900187     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Asami O, Ihara I, Shimidzu N, Shimizu S, Tomita Y, Ichihara A, and Nakamura T (1991). Purification and characterization of hepatocyte growth factor from injured liver of carbon tetrachloride-treated rats. J Biochem 109:8-13.
2. Bajou K, Noel A, Gerard RD, Masson V, Brunner N, Holst Hansen C, Skobe M, Fusenig NE, Carmeliet P, Collen D, and Foidart JM (1998). Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization. Nat Med 4:923-928.
3. Ballaun C, Weninger W, Uthman A, Weich H, and Tschachler E (1995). Human keratinocytes express the three major splice forms of vascular endothelial growth factor. J Invest Dermatol 104:7-10.
4. Bottaro DP, Rubin JS, Faletto DL, Chan AM, Kmiecik TE, Vande WG, and Aaronson SA (1991). Identification of the hepatocyte growth factor receptor as the c-met protooncogene product. Science 251:802-804.
5. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, and Fusenig NE (1998). Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 106:761-771.
6. Boxman IL, Quax PH, Lowik CW, Papapoulos SE, Verheijen J, and Ponec M (1995). Differential regulation of plasminogen activation in normal keratinocytes and SCC-4 cells by fibroblasts. J Invest Dermatol 104:374-378.
7. Brown LF, Van-de WL, Harvey VS, and Dvorak HF (1988). Fibrinogen influx and accumulation of cross-linked fibrin in healing wounds and in tumor stroma. Am J Pathol 130:455-465.
8. Brown LF, Yeo KT, Berse B, Yeo TK, Senger DR, Dvorak HF, and Van-de WL (1992). Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J Exp Med 176:13751379.
9. Carroll VA, Griffiths MR, Geiger M, Merlo C, Furlan M, Lammle B, and Binder BR (1997). Plasma protein C inhibitor is elevated in survivors of myocardial infarction. Arterioscler Thromb Vase Biol 17:114-117.
10. Chomczynski P and Sacchi N (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal Biochem 162:156-159.
11. Chowdhury A, Fukuda R, and Fukumoto S (1996). Growth factor mRNA expression in normal colorectal mucosa and in uninvolved mucosa from ulcerative colitis patients. J Gastroenterol 31:353-360.
12. Claeys H, Sottrup JL, Zajdel M, Petersen TE, and Magnusson S (1976). Multiple gene duplication in the evolution of plasminogen. Five regions of sequence homology with the two internally homologous structures in prothrombin. FEBS Lett. 61:20-24.
13. Connolly DT, Heuvelman DM, Nelson R, Olander JV, Eppley BL, Delfino JJ, Siegel NR, Leimgruber RM, and Feder J (1989). Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 84:1470-1478.
14. de Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, and Williams LT (1992). The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255:989-991.
15. Dunsmore SE, Rubin JS, Kovacs SO, Chedid M, Parks WC, and Welgus HG (1996). Mechanisms of hepatocyte growth factor stimulation of keratinocyte metalloproteinase production. J Biol Chem 271:24576-24582.
16. Ferrara N, Houck K, Jakeman L, and Leung DW (1992). Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 13:18-32.
17. Frank S, Hubner G, Breier G, Longaker MT, Greenhalgh DG, and Werner S (1995). Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing. J Biol Chem 270:12607-12613.
18. Gherardi E, Sharpe M, Lane K, Sirulnik A, and Stoker M (1993). Hepatocyte growth factor/scatter factor (HGF/SF/SF), the c-met receptor and the behaviour of epithelial cells. Symp Soc Exp Biol 47:163-181.
19. Gille J, Khalik M, Koenig M, and Kaufmann R (1998). Hepatocyte growth factor/scatter factor (HGF/SF) induces vascular permeability factor (VPF/VEGF) expression by cultured keratinocytes. J Invest Dermatol 111:1160-1165.
20. Gohda E, Tsubouchi H, Nakayama H, Hirono S, Sakiyama O, Takahashi K, Miyazaki H, Hashimoto S, and Daikuhara Y (1988). Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure. J Clin Invest 81:414-419.
21. Gospodarowicz D, Abraham JA, and Schilling J (1989). Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells. Proc Natl Acad Sci USA 86:7311-7315.
22. Houck KA, Ferrara N, Winer J, Cachianes G, Li B, and Leung DW (1991). The vascular endothelial growth factor family: Identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol 5:1806-1814.
23. Keck PJ, Hauser SD, Krivi G, Sanzo K, Warren T, Feder J, and Connolly DT (1989). Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 246:1309-1312.
24. Koolwijk P, van EM, de VW, Vermeer MA, Weich HA, Hanemaaijer R, and van HV (1996). Cooperative effect of TNFalpha, bFGF, and VEGF on the formation of tubular structures of human microvascular endothelial cells in a fibrin matrix. Role of urokinase activity. J Cell Biol 132:1177-1188.
25. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, and Ferrara N (1989). Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246:1306-1309.
26. Mandriota SJ and Pepper MS (1997). Vascular endothelial growth factor-induced in vitro angiogenesis and plasminogen activator expression are dependent on endogenous basic fibroblast growth factor. J Cell Sci 110:2293-2302.
27. Mandriota SJ, Seghezzi G, Vassalli JD, Ferrara N, Wasi S, Mazzieri R, Mignatti P, and Pepper MS (1995). Vascular endothelial growth factor increases urokinase receptor expression in vascular endothelial cells. J Biol Chem 270:9709-9716.
28. Matsumoto K and Nakamura T (1996). Emerging multipotent aspects of hepatocyte growth factor. J Biochem 119:591-600.
29. Matsumoto K, Hashimoto K, Yoshikawa K, and Nakamura T (1991). Marked stimulation of growth and motility of human keratinocytes by hepatocyte growth factor. Exp Cell Res 196:114-120.
30. Matsumoto K, Tajima H, Hamanoue M, Kohno S, Kinoshita T, and Nakamura T (1992). Identification and characterization of "injurin," an inducer of expression of the gene for hepatocyte growth factor. Proc Natl Acad Sci USA 89:3800-3804.
31. Miyazawa K, Tsubouchi H, Naka D, Takahashi K, Okigaki M, Arakaki N, Nakayama H, Hirono S, Sakiyama O, Takahashi K, Gohda E, Daikuhara Y, and Kitamura N (1989). Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor. Biochem Biophys Res Commun 163:967-973.
32. Miyazaki M, Gohda E, Tsuboi S, Tsubouchi H, Daikuhara Y, Namba M, and Yamamoto I (1992). Human hepatocyte growth factor stimulates the growth of HUH-6 clone 5 human hepatoblastoma cells. Cell Biol Int Rep 16:145-154.
33. Naka D, Ishii T, Yoshiyama Y, Miyazawa K, Hara H, Hishida T, and Kidamura N (1992). Activation of hepatocyte growth factor by proteolytic conversion of a single chain form to a heterodimer. J Biol Chem 267:20114-20119.
34. Nakamura T, Nawa K, and Ichihara A (1984). Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun 122:1450-1459.
35. Nakamura T, Teramoto H, and Ichihara A (1986). Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary cultures. Proc Natl Acad Sci USA 83:6489-6493.
36. Nakamura T, Nawa K, Ichihara A, Kaise N, and Nishino T (1987). Purification and subunit structure of hepatocyte growth factor from rat platelets. FEBS Lett 224:311-316.
37. Nakamura T, Nishizawa T, Hagiya M, Seki T, Shimonishi M, Sugimura A, Tashiro K, and Shimizu S (1989). Molecular cloning and expression of human hepatocyte growth factor. Nature 342:440-443.
38. Naldini L, Vigna E, Narsimhan RP, Gaudino G, Zarnegar R, Michalopoulos GK, and Comoglio PM (1991a). Hepatocyte growth factor (HGF/SF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-MET. Oncogene 6:501-504.
39. Naldini L, Weidner KM, Vigna E, Gaudino G, Bardelli A, Ponzetto C, Narsimhan RP, Hartmann G, Zarnegar R, and Michalopoulos GK (1991b). Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor. EMBO J 10:2867-2878.
40. Naldini L, Tamagnone L, Vigna E, Sachs M, Hartmann G, Birchmeier W, Daikuhara Y, Tsubouchi H, Blasi F, and Comoglio PM (1992). Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor. EMBO J 11:4825-4833.
41. Pammer J, Weninger W, Mildner M, Burian M, Wojta J, and Tschachler E (1998). Vascular endothelial growth factor is constitutively expressed in normal human salivary glands and is secreted in the saliva of healthy individuals. J Pathol 186:186-191.
42. Panos RJ, Patel R, and Bak PM (1996). Intratracheal administration of hepatocyte growth factor/scatter factor stimulates rat alveolar type II cell proliferation in vivo. Am J Respir Cell Mol Biol 15:574-581.
43. Pepper MS, Ferrara N, Orci L, and Montesano R (1991). Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem Biophys Res Commun 181:902-906.
44. Plettenberg A, Ballaun C, Pammer J, Mildner M, Strunk D, Weninger W, and Tschachler E (1995). Human melanocytes and melanoma cells constitutively express the Bcl-2 protooncogene in situ and in cell culture. Am J Pathol 146:651-659.
45. Romer J, Bugge TH, Pyke C, Lund LR, Flick MJ, Degen JL, and Dano K (1996). Impaired wound healing in mice with a disrupted plasminogen gene. Nat Med 2:287-292.
46. Romer J, Lund LR, Eriksen J, Ralfkiaer E, Zeheb R, Gelehrter TD, Dano K, and Kristensen P (1991). Differential expression of urokinase-type plasminogen activator and its type-1 inhibitor during healing of mouse skin wounds. J Invest Dermatol 97:803-811.
47. Rosen EM, Goldberg ID, Kacinski BM, Buckholz T, and Vinter DW (1989). Smooth muscle releases an epithelial cell scatter factor which binds to heparin. In Vitro Cell Dev Biol 25:163-173.
48. Sakai T, Satoh K, Matsushima K, Shindo S, Abe S, Abe T, Motomiya M, Kawamoto T, Kawabata Y, Nakamura T, and Nukiwa T (1997). Hepatocyte growth factor in bronchoalveolar lavage fluids and cells in patients with inflammatory chest diseases of the lower respiratory tract: Detection by RIA and in situ hybridization. Am J Respir Cell Mol Biol 16:388-397.
49. Sato C, Tsuboi R, Shi CM, Rubin JS, and Ogawa H (1995). Comparative study of hepatocyte growth factor/scatter factor and keratinocyte growth factor effects on human keratinocytes. J Invest Dermatol 104:958-963.
50. Schaefer BM, Stark HJ, Fusenig NE, Todd RF, and Kramer MD (1995). Differential expression of urokinase-type plasminogen activator (uPA), its receptor (uPA-R), and inhibitor type-2 (PAI-2) during differentiation of keratinocytes in an organotypic co-culture system. Exp Cell Res 220:415-423.
51. Seki T, Ihara I, Sugimura A, Shimonishi M, Nishizawa T, Asami O, Hagiya M, Nakamura T, and Shimizu S (1990). Isolation and expression of cDNA for different forms of hepatocyte growth factor from human leukocyte. Biochem Biophys Res Commun 172:321-327.
52. Shima N, Nagao M, Ogaki F, Tsuda E, Murakami A, and Higashio K (1991). Tumor cytotoxic factor/hepatocyte growth factor from human fibroblasts: Cloning of its cDNA, purification and characterization of recombinant protein. Biochem Biophys Res Commun 180:1151-1158.
53. Staiano CL, Carano K, Allan VM, Steiner MG, Pagan CI, Bailey BB, Babaar P, Rigas B, and Higgins PJ (1996). PAI-1 gene expression is growth state-regulated in cultured human epidermal keratinocytes during progression to confluence and postwounding. Exp Cell Res 227:123-134.
54. Stefansson S and Lawrence DA (1996). The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin. Nature 383:441-443.
55. Stoker M and Perryman M (1985). An epithelial scatter factor released by embryo fibroblasts. J Cell Sci 77:209-223.
56. Stoker M, Gherardi E, Perryman M, and Gray J (1987). Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature 327:239-342.
57. Strain AJ, Ismail T, Tsubouchi H, Arakaki N, Hishida T, Kitamura N, Daikuhara Y, and McMaster P (1991). Native and recombinant human hepatocyte growth factors are highly potent promoters of DNA synthesis in both human and rat hepatocytes. J Clin Invest 87:1853-1587.
58. Sugawara J, Fukaya T, Murakami T, Yoshida H, and Yajima A (1997). Hepatocyte growth factor stimulated proliferation, migration, and lumen formation of human endometrial epithelial cells in vitro. Biol Reprod 57:936-942.
59. Takahashi M, Ota S, Hata Y, Mikami Y, Azuma N, Nakamura T, Terano A, and Omata M (1996). Hepatocyte growth factor as a key to modulate anti-ulcer action of prostaglandins in stomach. J Clin Invest 98:2604-2611.
60. Taman M, Liu Y, Tolbert E, and Dworkin LD (1997). Increase urinary hepatocyte growth factor excretion in human acute renal failure. Clin Nephrol 48:241-245.
61. Tamura M, Arakaki N, Tsubouchi H, Takada H, and Daikuhara Y (1993). Enhancement of human hepatocyte growth factor production by interleukin-1 alpha and -1 beta and tumor necrosis factor-alpha by fibroblasts in culture. J Biol Chem 268:8140-8145.
62. Van Belle E, Witzenbichler B, Chen D, Silver M, Chang L, Schwall R, and Isner JM (1998). Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: The case for paracrine amplification of angiogenesis. Circulation 97:381-390.
63. Wakitani S, Imoto K, Kimura T, Ochi T, Matsumoto K, and Nakamura T (1997). Hepatocyte growth factor facilitates cartilage repair. Full thickness articular cartilage defect studied in rabbit knees. Acta Orthop Scand 68:474-480.
64. Wang MH, Dlugosz AA, Sun Y, Suda T, Skeel A, and Leonard EJ (1996). Macrophage-stimulating protein induces proliferation and migration of murine keratinocytes. Exp Cell Res 226:39-46.
65. Weidner KM, Arakaki N, Hartmann G, Vandekerckhove J, Weingart S, Rieder H, Fonatsch C, Tsubouchi H, Hishida T, Daikuhara Y, Birchmeier W (1991). Evidence for the identity of human scatter factor and human hepatocyte growth factor. Proc Natl Acad Sci USA 88:7001-7005.
66. Wojta J, Holzer M, Hufnagl P, Christ G, Hoover RL, and Binder BR (1991). Hyperthermia stimulates plasminogen activator inhibitor type 1 expression in human umbilical vein endothelial cells in vitro. Am J Pathol 139:911-919.